BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 30399371)

  • 1. Long noncoding RNA GHET1 in human cancer.
    Li J; Jiang X; Li Z; Huang L; Zhou Y; Liu Y; Cui Y
    Clin Chim Acta; 2019 Jan; 488():111-115. PubMed ID: 30399371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological Significance of Long Non-Coding RNA GHET1 in Human Cancers: A Meta-Analysis.
    Poursheikhani A; Nokhandani N; Yousefi H; Rad DM; Sahebkar A
    Curr Pharm Biotechnol; 2020; 21(14):1422-1432. PubMed ID: 32720600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.
    Yang F; Xue X; Zheng L; Bi J; Zhou Y; Zhi K; Gu Y; Fang G
    FEBS J; 2014 Feb; 281(3):802-13. PubMed ID: 24397586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
    Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
    J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
    Song R; Zhang J; Huang J; Hai T
    Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PANDAR: a pivotal cancer-related long non-coding RNA in human cancers.
    Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X
    Mol Biosyst; 2017 Oct; 13(11):2195-2201. PubMed ID: 28976505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA GHET1 down-regulation suppresses the cell activities of glioma.
    Ni W; Luo L; Zuo P; Li RP; Xu XB; Wen F; Hu D
    Cancer Biomark; 2018; 23(1):9-22. PubMed ID: 30103301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers.
    Zheng QX; Wang J; Gu XY; Huang CH; Chen C; Hong M; Chen Z
    Biomed Pharmacother; 2021 Mar; 135():111169. PubMed ID: 33433359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding SNHG1 in cancer.
    Thin KZ; Tu JC; Raveendran S
    Clin Chim Acta; 2019 Jul; 494():38-47. PubMed ID: 30849309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GHET1 acts as a prognostic indicator and functions as an oncogenic lncRNA in cervical cancer.
    Zhang Q; Zhang Y; Wang Y
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30948501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNAs and neoplasia.
    Isin M; Dalay N
    Clin Chim Acta; 2015 Apr; 444():280-8. PubMed ID: 25748036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dual functions of the long noncoding RNA CASC15 in malignancy.
    Gu X; Chu Q; Zheng Q; Wang J; Zhu H
    Biomed Pharmacother; 2021 Mar; 135():111212. PubMed ID: 33433353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TUG1: a pivotal oncogenic long non-coding RNA of human cancers.
    Li Z; Shen J; Chan MT; Wu WK
    Cell Prolif; 2016 Aug; 49(4):471-5. PubMed ID: 27339553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer.
    Wang J; Su Z; Lu S; Fu W; Liu Z; Jiang X; Tai S
    Clin Chim Acta; 2018 Oct; 485():229-233. PubMed ID: 29981289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of long noncoding RNA GHET1 inhibits cell‑cycle progression and invasion of gastric cancer cells.
    Xia Y; Yan Z; Wan Y; Wei S; Bi Y; Zhao J; Liu J; Liao DJ; Huang H
    Mol Med Rep; 2018 Sep; 18(3):3375-3381. PubMed ID: 30066922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers.
    Hu Q; Tai S; Wang J
    Pathol Res Pract; 2019 May; 215(5):843-848. PubMed ID: 30723052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of LncRNA GHET1 expression in various cancers: a systematic review and meta-analysis.
    Ye J; Sun H; Feng Z; Zhang Q; Xia Y; Ji Y; Zhang Q
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31227613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZEB1-AS1: A crucial cancer-related long non-coding RNA.
    Li J; Li Z; Leng K; Xu Y; Ji D; Huang L; Cui Y; Jiang X
    Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29226522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA GHET1 promotes esophageal squamous cell carcinoma cells proliferation and invasion via induction of EMT.
    Liu H; Zhen Q; Fan Y
    Int J Biol Markers; 2017 Oct; 32(4):e403-e408. PubMed ID: 28983895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.